Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
94
TGA:90
CANADA:2
Drug Approvals
FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe with attached needle (452626)
- Product Name
- FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe with attached needle
- Approval Date
- Jul 10, 2025
TGA
FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free (452625)
- Product Name
- FLUCELVAX trivalent influenza vaccine (surface antigen, inactivated), suspension for injection pre-filled syringe needle free
- Approval Date
- Jul 10, 2025
TGA
AUDENZ Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free (446671)
- Product Name
- Audenz Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
- Approval Date
- Jun 11, 2025
TGA
CELLDEMIC Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free (446673)
- Product Name
- Celldemic Pre-pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
- Approval Date
- Jun 11, 2025
TGA
RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle (473905)
- Product Name
- RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle
- Approval Date
- Mar 28, 2025
TGA
CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free (446874)
- Product Name
- CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free
- Approval Date
- Apr 26, 2024
TGA
ONAKTA tirbanibulin 1% w/w ointment sachet (391198)
- Product Name
- ONAKTA tirbanibulin 1% w/w ointment sachet
- Approval Date
- Feb 23, 2024
TGA
Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial (421511)
- Product Name
- Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial
- Approval Date
- Oct 6, 2023
TGA
FLUAD QUAD prefilled syringe(Influenza Surface Antigen,MF59C.1 adjuvanted vaccine) (410927)
- Product Name
- FLUAD QUAD prefilled syringe(Influenza Surface Antigen,MF59C.1 adjuvanted vaccine)
- Approval Date
- Jun 20, 2023
TGA
TAVNEOS avacopan 10 mg hard capsule bottle (381053)
- Product Name
- TAVNEOS avacopan 10 mg hard capsule bottle
- Approval Date
- Jan 31, 2023
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)No trials found
News
No news found